SCHEMBL25112892

SCHEMBL25112892

c1cnc2c(c1)cc(-c1ccc(-c3ccc4c(c3)c3ccccc3c3cccc5ccc6cccc4c6c53)cc1)c1cccnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.43
CCR8 P51685 5/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 2/20 0.42
THRB P10828 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
CCR5 P51681 3/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 2/20 0.39
GMNN O75496 1/20 0.39
TP53 P04637 1/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112962 0.94 CCR1 (0.40) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL25112992 0.91 CCR1 (0.40) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL25112873 0.91 CCR1 (0.42) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL25112810 0.88 CCR1 (0.42) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL25112912 0.86 CCR1 (0.45) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL25112920 0.85 CCR1 (0.40) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL25112932 0.85 CCR1 (0.40) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL17680297 0.85 CCR1 (0.46) CCR1CCR8L3MBTL1ALDH1A1CYP1A2
SCHEMBL17343965 0.85 CYP11B1 (0.46) CCR1CCR8L3MBTL1ALDH1A1HPGD
SCHEMBL17343953 0.85 CYP11B1 (0.46) CCR1CCR8L3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 CCR1 1810/4885CCR8 3519/4885L3MBTL1 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.